Core Insights - Safety Shot, Inc. has received its first revenue share payment of $500,000 from its 10% interest in letsBONK.fun and plans to reinvest this into acquiring more BONK tokens [2][5] - The company aims to increase its holdings of BONK to 5% of the total circulating supply by the end of 2025, currently holding over 2.7% [1][5] - The strategy involves leveraging a non-dilutive revenue stream to accumulate BONK tokens during a market downturn, taking advantage of perceived discounts [3][5] Financial Performance - The company anticipates an additional revenue share payment of approximately $650,000 within the next 27 days [2] - The strong, debt-free balance sheet allows the company to act decisively in acquiring digital assets [3][5] Market Strategy - Historically, the fourth quarter, especially October and November, has seen significant price appreciation for the BONK token, positioning the company to capitalize on seasonal trends [4][5] - The approach aims to create a powerful flywheel for shareholder value by systematically growing the digital asset treasury using operational revenue [5] Company Overview - Safety Shot, Inc. is focused on bridging traditional public markets with the digital asset ecosystem, particularly through revenue-generating assets in the DeFi space [6]

Core Insights - Safety Shot, Inc. has appointed three new directors with expertise in venture capital, financial due diligence, and Bitcoin mining to support its growth strategy [1][2][3] - The new board composition will consist of seven members, with a majority aligned with the company's subsidiary, BONK Holdings LLC [2] - The company aims to bridge traditional public markets with the digital asset ecosystem and is focusing on acquiring revenue-generating assets in the DeFi space [3] New Board Members - Connor Klein, an investment partner at New Form Capital, has a background in financial infrastructure, real-world assets, and DeFi, previously working at Morgan Stanley and a crypto payments startup [4] - Stacey Duffy is a financial due diligence expert with experience in complex transactions for corporate and private equity clients, having worked at Alvarez & Marsal and KPMG [4] - Jamie McAvity, co-founder and CEO of Bitcoin mining company Cormint, has scaled operations to 130MW and has been recognized for efficiency in Bitcoin mining [4] Strategic Direction - The appointments are intended to enhance the company's capabilities in digital assets and high-growth operations, particularly in relation to BONK Holdings [2][3] - The CEO of Safety Shot emphasized the importance of the new directors' expertise in executing the company's vision and unlocking the value of its beverage division [3]

Core Insights - Safety Shot, Inc. has formed a new subsidiary, BONK Holdings LLC, to manage its digital asset strategy and has executed a $5 million purchase to increase its BONK treasury to over $63 million [1][2] Group 1: Company Strategy - BONK Holdings has built its treasury through previous raises and a recent $5 million purchase, acquiring approximately 228.9 billion $BONK at an average cost of $0.00002184, now holding over 2.5% of the total circulating supply valued at around $55 million [2] - The company aims to unlock intrinsic value for shareholders and plans to actively manage its BONK treasury by participating in the Solana DeFi ecosystem through staking, providing liquidity, and yield farming, which is expected to generate non-dilutive returns [3] - The formation of BONK Holdings and the partnership with FalconX are seen as pivotal steps in establishing a premier publicly traded vehicle for the BONK ecosystem, with the current digital and cash assets valued above the entire market cap [4] Group 2: Revenue Generation - The company has a 10% revenue sharing interest from the profitable letsBONK.fun platform, which will fund ongoing BONK token acquisitions once custody practices are finalized [4] - Safety Shot is focused on acquiring revenue-generating assets within the DeFi space to build a robust treasury of digital assets, bridging traditional public markets and the digital asset ecosystem [5]

Core Viewpoint - Safety Shot, Inc. has appointed Markita L. Russell as the new Chief Financial Officer, bringing over 30 years of financial and accounting experience to the role, which is expected to support the company's growth and strategic initiatives [1][4]. Company Overview - Safety Shot, Inc. is a wellness and dietary supplement company known for its product Sure Shot, which is designed to lower blood alcohol content while enhancing clarity, energy, and mood [5]. - The company is expanding its business-to-business sales of Sure Shot to various distributors, retailers, restaurants, and bars throughout 2025 [5]. Leadership Background - Markita L. Russell has been with Safety Shot since August 2021 as the Controller and has a strong background in managing financial operations across diverse industries, including beverage, law, technology, and real estate [2][3]. - Notably, she played a key role in growing a marine industry company from $7 million in gross revenue in 2012 to $56.8 million by the end of 2020, showcasing her capability in managing significant growth [3]. Strategic Importance - The CEO of Safety Shot, Jarrett Boon, expressed confidence in Russell's financial acumen and her experience in the beverage industry, which will be crucial for the company's expansion and integration of new strategic initiatives [4]. - Russell emphasized her commitment to fortifying the company's financial operations and driving long-term shareholder value during this pivotal time for Safety Shot [4].

Core Viewpoint - Safety Shot, Inc. has announced a registered direct offering and concurrent private placement to raise approximately $16.3 million, which will strengthen its balance sheet and support its operations following the recent merger approval with Yerbaé [1][3][5]. Group 1: Offering Details - The company is offering 22,993,492 shares of common stock at a price of $0.461 per share [1]. - In addition, warrants to purchase up to 45,986,984 shares of common stock have been issued, with a purchase price of $0.125 per warrant and an exercise price of $0.461 per share [2]. - The gross proceeds from both the registered direct offering and the private placement are expected to be around $16.3 million before fees and expenses [3]. Group 2: Strategic Importance - The CEO of Safety Shot emphasized that this financing is crucial for the company at a pivotal time, enhancing the balance sheet and providing necessary capital for daily operations and integration post-merger [5]. - The company aims to accelerate its commercial footprint and drive long-term value for shareholders with this capital infusion [5]. Group 3: Regulatory Information - The shares are being offered under a shelf registration statement filed with the SEC, which was declared effective on November 9, 2022 [4]. - A prospectus supplement detailing the terms of the offering will be filed with the SEC and made available on their website [4]. Group 4: Company Overview - Safety Shot, Inc. specializes in wellness and dietary supplements, with its flagship product, Sure Shot, designed to lower blood alcohol content while enhancing clarity and mood [7]. - The product is available for purchase on various online platforms, including Walmart and Amazon [7].

Group 1 - Safety Shot, Inc. announced a registered direct offering of 28,648,648 shares of common stock at a price of $0.37 per share, raising approximately $10.6 million in gross proceeds [1][2]. - In a concurrent private placement, the company issued warrants to purchase up to 57,297,296 shares of common stock, with an exercise price of $0.37 per share, exercisable immediately and expiring in five years [2]. - The closing of the offering is expected to occur on or about July 22, 2025 [3]. Group 2 - The shares are being offered under a shelf registration statement filed with the SEC, which was declared effective on November 1, 2024 [4]. - The CEO of Safety Shot emphasized that this financing is crucial for strengthening the balance sheet and supporting expanded operations following the recent merger approval with Yerbaé [5]. - Dominari Securities, LLC acted as the exclusive placement agent for the offering [5]. Group 3 - Safety Shot, Inc. is known for its patented wellness product, Sure Shot, which lowers blood alcohol content while enhancing clarity, energy, and mood [7].

Core Points - Safety Shot, Inc. has received a 180-calendar day extension from Nasdaq to regain compliance with the minimum bid price requirement, now due by December 29, 2025 [1][4] - The company meets all other Nasdaq listing requirements except for the bid price, and has expressed intention to address this deficiency during the compliance period [2] - The company's common stock will continue to trade on Nasdaq under the ticker symbol "SHOT" without immediate effect from this notification [3] Company Strategy - The CEO of Safety Shot has indicated that the Board of Directors has approved several strategic options to meet the bid price requirement [4] - The company aims to maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the compliance period to regain compliance [4] - If compliance is not achieved by the deadline, the company may appeal any delisting decision to a Nasdaq Hearings Panel [4] Product Information - Safety Shot, Inc. specializes in wellness and dietary supplements, with its flagship product, Sure Shot, designed to lower blood alcohol content while enhancing clarity, energy, and mood [5]

Core Insights - Yerbaé Brands Corp. has successfully completed a business combination with Safety Shot, Inc., where Safety Shot acquired all outstanding shares of Yerbaé [1][2] - The transaction was executed through a court-approved plan of arrangement, resulting in Safety Shot shareholders owning approximately 81.64% of the combined company, while former Yerbaé shareholders own about 18.36% [2][3] Transaction Overview - Under the arrangement agreement dated January 7, 2025, Safety Shot acquired all Yerbaé shares, with each Yerbaé shareholder receiving 0.2918 of a Safety Shot share for each Yerbaé share held [3] - The total number of Safety Shot shares issued in the transaction was 19,881,948 [2] - Yerbaé shares will be delisted from the TSX Venture Exchange and OTCQX effective June 30, 2025 [3] Shareholder Information - Yerbaé shareholders with physical share certificates must submit a Letter of Transmittal to receive their Safety Shot shares [4] - For shareholders holding shares in book-entry form or brokerage accounts, the exchange of shares is automatic [5] Company Profiles - Safety Shot, Inc. specializes in wellness and dietary supplements, notably developing Sure Shot, a patented product that lowers blood alcohol content while enhancing clarity and energy [6] - Yerbaé Brands Corp. produces plant-based energy beverages that are zero calorie, zero sugar, and cater to various dietary preferences, aiming to disrupt the energy beverage market [7] Advisory Information - Maxim Group LLC acted as the exclusive financial advisor to Safety Shot during the merger [8] - Legal counsel for Yerbaé was provided by Cozen O'Connor LLP, while Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. served as legal counsel for Safety Shot [9]

Acquisition Update - Safety Shot, Inc. has announced an update regarding the acquisition of Yerbaé Brands Corp., with the closing expected to finalize next week after stockholder approval on June 12, 2025 [1][2] - The delay in closing is attributed to the need for final administrative steps and scheduling adjustments following a shortened holiday week [2] Company Profiles - Safety Shot, Inc. is a wellness and dietary supplement company known for its patented product, Sure Shot, which lowers blood alcohol content while enhancing clarity, energy, and mood [4] - Sure Shot is available for purchase online and the company plans to expand its business-to-business sales throughout 2025 [4] - Yerbaé Brands Corp. is a plant-based functional beverage company that offers zero-sugar, zero-calorie energy drinks, appealing to health-conscious consumers [5]

Core Insights - Safety Shot, Inc. is expanding its patented wellness approach into the high-growth cognitive and restorative sleep markets, focusing on scientific rigor and unique formulations [1][3] - The company aims to leverage its expertise in developing its existing product, Sure Shot, to create new nootropic and sleep aid products [3][4] Company Developments - Safety Shot is initiating research and development for new product lines targeting nootropics and sleep aids, with prototypes expected later this year [1][6] - The company emphasizes a commitment to efficacy and tangible results, with a focus on advanced technologies to create distinct advantages in the market [4][6] Market Potential - The global nootropics supplements market is valued at approximately $6.5 billion and is projected to exceed $14.9 billion by 2034, with a compound annual growth rate (CAGR) of 8.7% [5] - The sleep-related supplements market was valued at $6.8 billion in 2023, with an anticipated CAGR of 5.1%, reaching $11.8 billion by 2034 [5] Product Focus - The new nootropic product will be engineered to enhance focus, cognition, and overall brain health for daily use [7] - The sleep aid aims to improve sleep quality and duration, addressing the critical role of sleep in productivity and mental clarity, with a unique formulation not typically found in existing products [7]